Objective aneuploidy detection for fetal and neonatal screening using comparative genomic hybridization (CGH)

Area of Science:

• Genetics
• Genomics
• Medical Diagnostics

Background:

• Comparative genomic hybridization (CGH) is a technique used to detect whole and segmental aneuploidy across entire genomes.
• Accurate detection of clinically significant chromosomal aberrations in fetal and neonatal screening requires robust methods to distinguish true abnormalities from experimental noise.

Purpose of the Study:

• To develop and evaluate a t-statistic method for identifying significant changes in CGH profiles.
• To assess the utility of the t-statistic for detecting aneuploidies in fetal and neonatal patient samples.

Main Methods:

• Utilized a t-statistic approach to analyze CGH profiles.
• Compared CGH profiles from eleven fetal and neonatal cell lines with known aneuploidies against normal sample variations.
• Applied the t-statistic to detect significant deviations indicative of chromosomal aberrations.

Main Results:

• The t-statistic successfully detected aneuploidies in all eleven patient samples, including trisomies (13, 16, 18, 21) and monosomies (5p, 18p).
• While detection was accurate, the precise estimation of the extent of the aneuploid region was not consistently achieved in all cases.
• The t-statistic provided a reliable means to identify the presence of aneuploidy.

Conclusions:

• The t-statistic is a valuable tool for enhancing the detection of chromosomal abnormalities using CGH in fetal and neonatal screening.
• Further refinement may be needed to improve the accuracy of defining the exact boundaries of aneuploid regions.
• This method offers improved sensitivity for identifying clinically relevant genomic aberrations.